Hemostemix Inc. faced a significant drop in its stock price today, closing down 7.69%.
In the latest trading session, Hemostemix Inc. (HEM.V) saw its stock price fall to CA$0.06, marking a notable decline. This downturn raises questions about the company's current standing and future prospects.
Advertisement
Get up to $2,000 cash back
Open and fund a new Qtrade account with promo code SPRING26. Offer ends July 31, 2026.
Hemostemix Inc
HEM.V
HEM.V
Hemostemix Inc
WealthAwesomeMarket cap
$12.30M
52W high
$0.14
52W low
$0.04
1W change
+8.33%
Beta
0.62
Analyst Price Targets
Based on analyst covering HEM
Wall Street analysts forecast HEM stock price to rise 1376.9% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$0.96
+1376.9% Upside
Current Price
C$0.07
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on HEM's historical volatility
30-Day Vol
136.1%
Annualized
90-Day Vol
109.7%
Annualized
Trend (90d)
-0.0%
Annualized drift
90d Mean
C$0.06
Expected price
| Horizon | Expected | 68% Range (1ฯ) |
|---|---|---|
| 30 trading days | C$0.06 | C$0.04 โ C$0.10 |
| 60 trading days | C$0.06 | C$0.03 โ C$0.13 |
| 90 trading days | C$0.06 | C$0.03 โ C$0.15 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ยฑ1ฯ, 95% band = ยฑ2ฯ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Investor takeaway: Investors should be cautious as Hemostemix's reliance on private placements and lack of recent positive news may be contributing to its declining stock performance.
Hemostemix Inc. Stock Drops 7.69% in One Day
The stock's market cap now stands at CA$13.32 million, reflecting investor concerns about its financial health.
Bull case
If Hemostemix can effectively use the funds from its recent private placements to advance its regulatory and clinical initiatives, there might be a chance for its stock price to recover.
Bear case
However, if the company continues to depend on private funding without achieving significant operational milestones or generating revenue, it may face further declines as investor confidence decreases.
Recent Performance Overview
Hemostemix Inc. has had a troubling performance lately, with today's 7.69% drop adding to concerns about its viability. The company's stock closed at CA$0.06, reflecting a market cap of approximately CA$13.32 million. Investors are left questioning the sustainability of its operations amid ongoing reliance on private placements.
Impact of Private Placements
The company has engaged in several private placements over the past months to raise funds, including a recent tranche that closed in November 2025. While these funds are intended to support operational initiatives, the lack of substantial news or progress may be leading to investor skepticism and the current stock decline. For more details, see the HEM.V stock page.
Looking Ahead
As Hemostemix navigates its current challenges, it will be crucial for the company to show tangible progress in its clinical and regulatory efforts. Without significant advancements or a shift in investor sentiment, the stock may continue to struggle. For ongoing updates, check back on the HEM.V stock page.
Advertisement
